Tamoxifen and contralateral breast cancer
- 1 June 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 188 (6) , 678-683
- https://doi.org/10.1016/s1072-7515(99)00057-5
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Preliminary Results From the Cancer Research Campaign Trial Evaluating Tamoxifen Duration in Women Aged Fifty Years or Older With Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary MalignanciesJNCI Journal of the National Cancer Institute, 1995
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Long-Term Effects of Adjuvant Tamoxifen and/or Radiotherapy: The South Sweden Breast Cancer TrialActa Oncologica, 1992
- Carcinogenic Effects of Adjuvant Tamoxifen Treatment and Radiotherapy for Early Breast CancerActa Oncologica, 1992
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancerCancer, 1989
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988